47
Participants
Start Date
July 31, 2010
Primary Completion Date
September 30, 2010
Ibuprofen
200 mg oral administration (RhinAdvil(R))
Ibuprofen
200 mg oral administration (BI product)
Pseudoephedrine-HCl
30 mg oral administration (BI product)
Pseudoephedrine-HCl
30 mg oral administration (RhinAdvil(R))
1024.7.1 Boehringer Ingelheim Investigational Site, Ingelheim
Lead Sponsor
Boehringer Ingelheim
INDUSTRY